Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Spacers (with metered dose inhalers) are used for treating respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD).

The increasing prevalence of respiratory diseases is expected to drive the global asthma spacers market growth during the forecast period. For instance, according to the World Health Organization (WHO), in 2017, around 65 million people suffered from moderate to severe chronic obstructive pulmonary disease, among which 3 million die every year globally.

The global asthma spacers market is estimated to be valued at US$ 1,573.4 million in 2020 and is expected to exhibit a CAGR of 6.4% during the forecast period (2020-2027).

Figure 1. Global Asthma Spacers Market Share (%) Analysis, By Spacers Type, 2020

Asthma Spacers  | Coherent Market Insights

The increasing prevalence of asthma is expected to drive the global asthma spacers market growth.

Respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) among others are highly prevalent worldwide. According to the World Health Organization (WHO), the number of people suffering from asthma as of November 2019 was around 235 million. According to the Centers for Disease Control and Prevention (CDC), around 27 million Americans were suffering from asthma in 2016. It is the most common chronic condition among American children, where 1 child out of every 12 has asthma.

Furthermore, according to the National Heart, Lung, and Blood Institute, in 2014, around 30% of children in the U.S. were suffering from asthma. Moreover, according to the same source, more than half of the people suffering from asthma experience a severe asthma attack each year, which leads to 450,000 hospitalizations, annually.

Furthermore, asthma is more prevalent among the aging population which is expected to facilitate the asthma spacers market growth in the U.S. According to the World Population Ageing report, in 2017, the number of people aged 60 years in the U.S. was 69,774, and the number is projected to reach 108,425 in 2050. Furthermore, the global population aged 60 years was 962 million in 2017 and it is expected to reach nearly 2.1 billion in 2050.

Asthma Spacers Market- Restraints

Asthma can be treated with bronchial thermoplasty which is a proven alternative treatment. It is used in cases where asthma drugs do not show the desired effects or fail to cure the condition.

In bronchial thermoplasty, the inside of the lungs’ airways are heated with electrodes to shrink the smooth muscle inside the airways. It controls the ability of the airways to tighten, which makes breathing easier and reduces incident of asthma attacks.

According to data published by the National Center for Biotechnology Information in May 2015, several clinical trials have demonstrated the safety and efficacy of bronchial thermoplasty in improving quality of life and reducing events of severe asthma attacks. Thus, availability of alternative treatments for asthma are expected to hinder the global asthma spacers market growth.

request-sample

Asthma Spacers Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 1,573.4 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.4% 2027 Value Projection: US$ 2,429.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Spacer Type: Volumatic, AeroChamber, InspirEase, OptiChamber.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Companies covered:

GlaxoSmithKline Plc., Truedell Medical International, Cipla Inc., Medical Developments International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V., Clement Clarke International Ltd., and Lupin Limited

Growth Drivers:
  • The increasing prevalence of asthma
  • An increasing number of initiatives by organization for asthma awareness
Restraints & Challenges:
  • Availability of alternative treatments for asthma

Asthma Spacers Market– Regional Analysis

North America accounted for the largest share in the asthma spacers market in 2019 as key players in the region are focusing on strategies such as mergers & acquisitions, product innovation, joint ventures, collaborations, and partnership to enhance their market position. For instance, in May 2017, Lupin Limited announced a partnership between its American subsidiary, Lupin Pharmaceuticals, Inc. (Lupin) and Albertsons Companies, to provide Lupin's InspiraChamber (a valved holding chamber for the enhanced delivery of inhaled aerosol therapies) to patients in more than 1,700 pharmacies in 35 states, including DC.

Furthermore, Asia Pacific is expected to observe the fastest growth during the forecast period owing to launch of asthma spacers. For instance, in April 2019, Cipla announced the launch of its inhaler, Niveoli, in India. It is India’s first extra-fine particle Beclomethasone-Formoterol combination Hydrofluoroalkane (HFA) inhaler for adults. It is indicated for treatment of obstructive airway diseases such as asthma.

Figure 2. Flobal Asthma Spacers Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Asthma Spacers  | Coherent Market Insights

Asthma Spacers Market- Competitive Landscape

Key players operating in the Asthma Spacers Market are GlaxoSmithKline Plc., Truedell Medical International, Cipla Inc., Medical Developments International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V., Clement Clarke International Ltd., and Lupin Limited.

Asthma is a chronic condition in which airways in the lungs swell and narrow due to production of extra mucus which causes difficulty in breathing. Spacers are tube like devices which are attached to inhalers and used for administering aerosolized medication.

Market Dynamics

The global asthma spacers market is expected to witness significant growth during the forecast period owing to the increasing prevalence of asthma. According to the National Center for Biotechnology Information, in January 2016, the prevalence of asthma in Poland for both urban and rural population was significantly high and accounted for 3.5% in the rural population and 4.1 % in the urban population.

Key features of the study:

  • This report provides in-depth analysis of the global asthma spacers market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global asthma spacers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study are GlaxoSmithKline Plc., Truedell Medical International, Cipla Inc., Medical Developments International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V., Clement Clarke International Ltd., and Lupin Limited
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global asthma spacers market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the asthma spacers market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Asthma Spacers Market, By Spacer Type:
    • Volumatic
    • AeroChamber
    • InspirEase
    • OptiChamber
  • Global Asthma Spacers Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Asthma Spacers Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Spacer Type:
        • Volumatic
        • AeroChamber
        • InspirEase
        • OptiChamber
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Spacer Type:
        • Volumatic
        • AeroChamber
        • InspirEase
        • OptiChamber
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Spacer Type:
        • Volumatic
        • AeroChamber
        • InspirEase
        • OptiChamber
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Spacer Type:
        • Volumatic
        • AeroChamber
        • InspirEase
        • OptiChamber
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Spacer Type:
        • Volumatic
        • AeroChamber
        • InspirEase
        • OptiChamber
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Spacer Type:
        • Volumatic
        • AeroChamber
        • InspirEase
        • OptiChamber
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
  • Company Profiles
    • GlaxoSmithKline Plc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Truedell Medical International
    • Cipla Inc.
    • Medical Developments International
    • PARI Respiratory Equipment, Inc.
    • Koninklijke Philips N.V.
    • Clement Clarke International Ltd.
    • Lupin Limited

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Spacer Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
    • Technological Advancements
    • Market Trends
    • Key Developments
  4. Impact Analysis of Covid-19
    • Supply side Analysis
    • Demand Side Analysis
    • Impact on Healthcare Industry
  5. Global Asthma Spacers Market, By Spacer Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Volumatic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • AeroChamber
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • InspirEase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • OptiChamber
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Asthma Spacers Market, By Distribution Channel, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Asthma Spacers Market, By Region, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Spacer Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Spacer Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Spacer Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Spacer Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Spacer Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Spacer Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • GlaxoSmithKline Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Truedell Medical International
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Cipla Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medical Developments International
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • PARI Respiratory Equipment, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Koninklijke Philips N.V.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Clement Clarke International Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Lupin Limited
        •  Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 27 figures on "Global Asthma Spacers Market” - Forecast to 2027”

Frequently Asked Questions

The CAGR of the asthma spacers market is expected to be 6.4% during the forecast period (2020-2027).
The value of asthma spacers market is estimated to be US$ 1,573.4 million in 2020.
The prominent players in the global asthma spacers market are GlaxoSmithKline Plc., Truedell Medical International, Cipla Inc., Medical Developments International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V., Clement Clarke International Ltd., and Lupin Limited.
The Asthma Spacers Market is expected to be valued at US$ 2,429.5 in 2027.
North America is the major region in the Asthma Spacers Market.
The increasing prevalence of asthma and initiatives by organization for asthma awareness are expected to drive growth of the global asthma spacers market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner